2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine(CAS: 396-01-0)

2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine (CAS: 396-01-0) is subject to various regulatory guidelines including the Globally Harmonized System (GHS) for classification and labeling, REACH regulations in the EU for registration, evaluation, authorization, and restriction, and FDA and EPA requirements for safety and environmental protection. Compliance with these regulations is essential for its handling and utilization.

There are several alternatives to 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine in synthesis, including related pteridines and similar nitrogen-containing heterocycles. These alternatives can offer comparable or improved properties, making them viable options depending on the specific application requirements.

The market for 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine is showing steady growth due to its applications in pharmaceuticals and biotechnology. Research trends are focusing on its potential as a biomarker, drug candidate, and for its use in developing novel therapeutics. Additionally, there is increasing interest in its environmental and toxicological properties.

Waste containing 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine should be collected in appropriate containers and stored under controlled conditions to prevent degradation and potential environmental release. Incineration or professional waste disposal services are recommended for safe disposal. Environmental protection precautions, including proper handling and disposal methods, must be followed to ensure compliance with regulatory standards and minimize environmental impact.